Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 10, 2024
Discovery & Translation

Science Spotlight: As miRNAs get Nobel Prize, targeting advances continue

BioCentury’s roundup of translational innovation also features Vedanta’s solution to GI infection, Takeda’s exon-skipping delivery tech, and more
BioCentury | Sep 6, 2022
Distillery Therapeutics

miR-21 for beta islet cell function in diabetes

BioCentury | Mar 4, 2022
Distillery Therapeutics

Antagonizing miR-21 to treat COPD

BioCentury | Sep 14, 2021
Translation in Brief

mRNA combos from BioNTech, Moderna; plus new CRISPR nucleases and more

BioCentury’s roundup of translational news
BioCentury | Jan 21, 2020
Tools & Techniques

Disney lab uncovers another RNA-binding small molecule for triple-negative breast cancer

The Disney lab expands its RNA-binding small molecule toolbox with targeted RNA degradation
BioCentury | Jul 11, 2018
Translation in Brief

The RNA Renaissance continues

How Disney’s Scripps lab has expanded the RNA target universe
BioCentury | Feb 8, 2018
Translation in Brief

Diverging pathways

Genetic differences in tumors could shed light on disparity in clinical outcomes
BioCentury | May 12, 2017
Company News

Regulus reducing headcount by 30%

Items per page:
1 - 10 of 44